D759+D745+D150

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Type II Diabetes Mellitus

Phase 1

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

CompletedNCT05452525

Chong Kun Dang PharmaceuticalType II Diabetes Mellitus

Start: 2022-07-26End: 2022-09-21Updated: 2022-10-18

Pharmacokinetics and Safety/Tolerability of CKD-379

CompletedNCT05719155

Chong Kun Dang PharmaceuticalType II Diabetes Mellitus

Start: 2023-02-27End: 2023-04-10Updated: 2023-05-11